How is it looking for CAR-T and Gene Therapies so far in 2022?
With almost a quarter gone by in 2022, it would be a natural tendency for the Gene Therapy enthusiasts and market observers to try and make some sense of the developments in the sector. For some it could be a mixed bag of experiences and ardent expectations at the same time. It is a mixed…
News Views